Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Drugs in Development, 2021, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.
Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Drugs in Development, 2021, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages are 2, 11, 15, 1, 2, 98 and 17 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 7 and 1 molecules, respectively.
Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021
Table of Contents
Introduction
Traumatic Brain Injury - Overview
Traumatic Brain Injury - Therapeutics Development
Traumatic Brain Injury - Therapeutics Assessment
Traumatic Brain Injury - Companies Involved in Therapeutics Development
Traumatic Brain Injury - Drug Profiles
Traumatic Brain Injury - Dormant Projects
Traumatic Brain Injury - Discontinued Products
Traumatic Brain Injury - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Traumatic Brain Injury, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Companies, 2021 (Contd..2)
Number of Products under Development by Companies, 2021 (Contd..3)
Number of Products under Development by Companies, 2021 (Contd..4)
Number of Products under Development by Companies, 2021 (Contd..5)
Number of Products under Development by Companies, 2021 (Contd..6)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Products under Development by Companies, 2021 (Contd..6)
Products under Development by Companies, 2021 (Contd..7)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Target, 2021 (Contd..2)
Number of Products by Stage and Target, 2021 (Contd..3)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021 (Contd..2)
Number of Products by Stage and Mechanism of Action, 2021 (Contd..3)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Traumatic Brain Injury - Pipeline by Abliva AB, 2021
Traumatic Brain Injury - Pipeline by AegisCN LLC, 2021
Traumatic Brain Injury - Pipeline by AivoCode LLP, 2021
Traumatic Brain Injury - Pipeline by ALSP Inc, 2021
Traumatic Brain Injury - Pipeline by AlzeCure Pharma AB, 2021
Traumatic Brain Injury - Pipeline by American CryoStem Corp, 2021
Traumatic Brain Injury - Pipeline by Amgen Inc, 2021
Traumatic Brain Injury - Pipeline by Anagin Inc, 2021
Traumatic Brain Injury - Pipeline by Angion Biomedica Corp, 2021
Traumatic Brain Injury - Pipeline by Anida Pharma Inc, 2021
Traumatic Brain Injury - Pipeline by Annovis Bio Inc, 2021
Traumatic Brain Injury - Pipeline by AntiRadical Therapeutics LLC, 2021
Traumatic Brain Injury - Pipeline by Aptinyx Inc, 2021
Traumatic Brain Injury - Pipeline by Astrocyte Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Astrogen Ltd, 2021
Traumatic Brain Injury - Pipeline by Athersys Inc, 2021
Traumatic Brain Injury - Pipeline by Avanir Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by B Cell Solutions Inc, 2021
Traumatic Brain Injury - Pipeline by Bessor Pharma LLC, 2021
Traumatic Brain Injury - Pipeline by Beyond Barriers Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by Biogen Inc, 2021
Traumatic Brain Injury - Pipeline by BioIncept LLC, 2021
Traumatic Brain Injury - Pipeline by Bioquark Inc, 2021
Traumatic Brain Injury - Pipeline by Brain-Gen LLC, 2021
Traumatic Brain Injury - Pipeline by CalciMedica Inc, 2021
Traumatic Brain Injury - Pipeline by Calico Life Sciences LLC, 2021
Traumatic Brain Injury - Pipeline by CavoGene LifeSciences, 2021
Traumatic Brain Injury - Pipeline by CellCure, 2021
Traumatic Brain Injury - Pipeline by Cellvation Inc, 2021
Traumatic Brain Injury - Pipeline by CereSpir Inc, 2021
Traumatic Brain Injury - Pipeline by Champignon Brands Inc, 2021
Traumatic Brain Injury - Pipeline by Chimerix Inc, 2021
Traumatic Brain Injury - Pipeline by Chrysalis BioTherapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by Cognosci Inc, 2021
Traumatic Brain Injury - Pipeline by Complement Pharma BV, 2021
Traumatic Brain Injury - Pipeline by Covis Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by DeckTherapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by Deha Pharmaceutical LLC, 2021
Traumatic Brain Injury - Pipeline by Eagle Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Eisai Co Ltd, 2021
Traumatic Brain Injury - Pipeline by Emerald Organic Products Inc, 2021
Traumatic Brain Injury - Pipeline by Epigen Biosciences Inc, 2021
Traumatic Brain Injury - Pipeline by Expesicor Inc, 2021
Traumatic Brain Injury - Pipeline by Fortuna Fix Inc, 2021
Traumatic Brain Injury - Pipeline by GABA Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by GNT Pharma Co Ltd, 2021
Traumatic Brain Injury - Pipeline by Hemarina SA, 2021
Traumatic Brain Injury - Pipeline by Hibernaid Inc, 2021
Traumatic Brain Injury - Pipeline by Hillhurst Biopharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Hope Biosciences LLC, 2021
Traumatic Brain Injury - Pipeline by Hoverink Biotechnologies Inc, 2021
Traumatic Brain Injury - Pipeline by ImmunoChem Therapeutics LLC, 2021
Traumatic Brain Injury - Pipeline by Incannex Healthcare Ltd, 2021
Traumatic Brain Injury - Pipeline by Inflammatory Response Research Inc, 2021
Traumatic Brain Injury - Pipeline by International Stem Cell Corp, 2021
Traumatic Brain Injury - Pipeline by Ischemix Inc, 2021
Traumatic Brain Injury - Pipeline by JT Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Kalytera Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by M et P Pharma AG, 2021
Traumatic Brain Injury - Pipeline by Mapreg SAS, 2021
Traumatic Brain Injury - Pipeline by Mercaptor Discoveries Inc, 2021
Traumatic Brain Injury - Pipeline by NeuExcell Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by NeurAegis Inc, 2021
Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Ltd, 2021
Traumatic Brain Injury - Pipeline by NeurExo Sciences LLC, 2021
Traumatic Brain Injury - Pipeline by Neurodon LLC, 2021
Traumatic Brain Injury - Pipeline by Neuronasal LLC, 2021
Traumatic Brain Injury - Pipeline by NeuroNascent Inc, 2021
Traumatic Brain Injury - Pipeline by Neuropathix Inc, 2021
Traumatic Brain Injury - Pipeline by Neuroplast BV, 2021
Traumatic Brain Injury - Pipeline by NeuroTheranostics Inc, 2021
Traumatic Brain Injury - Pipeline by NeuroTrauma Sciences LLC, 2021
Traumatic Brain Injury - Pipeline by New World Laboratories Inc, 2021
Traumatic Brain Injury - Pipeline by NoNO Inc, 2021
Traumatic Brain Injury - Pipeline by Noveome Biotherapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by NuvOx Pharma LLC, 2021
Traumatic Brain Injury - Pipeline by Nyrada Inc, 2021
Traumatic Brain Injury - Pipeline by Odyssey Group International Inc, 2021
Traumatic Brain Injury - Pipeline by OncoSynergy Inc, 2021
Traumatic Brain Injury - Pipeline by Orpheris Inc, 2021
Traumatic Brain Injury - Pipeline by Oxeia Biopharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Peptron Inc, 2021
Traumatic Brain Injury - Pipeline by Personalized Stem Cells Inc, 2021
Traumatic Brain Injury - Pipeline by PharmaTher Inc, 2021
Traumatic Brain Injury - Pipeline by PharmatrophiX Inc, 2021
Traumatic Brain Injury - Pipeline by Pinteon Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by Praetego Inc, 2021
Traumatic Brain Injury - Pipeline by ProNeurogen Inc, 2021
Traumatic Brain Injury - Pipeline by ProThera Biologics Inc, 2021
Traumatic Brain Injury - Pipeline by Protheragen Inc, 2021
Traumatic Brain Injury - Pipeline by Qrons Inc, 2021
Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Resolys Bio Inc, 2021
Traumatic Brain Injury - Pipeline by RHNanopharmacuticals LLC, 2021
Traumatic Brain Injury - Pipeline by Rubicon Biotechnology Inc, 2021
Traumatic Brain Injury - Pipeline by Samus Therapeutics Inc, 2021
Traumatic Brain Injury - Pipeline by SanBio Company Limited, 2021
Traumatic Brain Injury - Pipeline by SciSparc Ltd, 2021
Traumatic Brain Injury - Pipeline by Seneca Biopharma Inc, 2021
Traumatic Brain Injury - Pipeline by Shinkei Therapeutics LLC, 2021
Traumatic Brain Injury - Pipeline by Silver Creek Pharmaceuticals Inc, 2021
Traumatic Brain Injury - Pipeline by Spinogenix Inc, 2021
Traumatic Brain Injury - Pipeline by STATegics Inc, 2021
Traumatic Brain Injury - Pipeline by Stemedica Cell Technologies Inc, 2021
Traumatic Brain Injury - Pipeline by Swedish Orphan Biovitrum AB, 2021
Traumatic Brain Injury - Pipeline by Synaptogenix Inc, 2021
Traumatic Brain Injury - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Traumatic Brain Injury - Pipeline by Tetra Therapeutics, 2021
Traumatic Brain Injury - Pipeline by Thera Neuropharma Inc, 2021
Traumatic Brain Injury - Pipeline by Therapeutic Solutions International Inc, 2021
Traumatic Brain Injury - Pipeline by Theratome Bio Inc, 2021
Traumatic Brain Injury - Pipeline by TikoMed AB, 2021
Traumatic Brain Injury - Pipeline by Tria Bioscience Corp, 2021
Traumatic Brain Injury - Pipeline by Trigemina Inc, 2021
Traumatic Brain Injury - Pipeline by vasopharm GmbH, 2021
Traumatic Brain Injury - Pipeline by VG Life Sciences Inc, 2021
Traumatic Brain Injury - Pipeline by Virogenomics BioDevelopment Inc, 2021
Traumatic Brain Injury - Pipeline by Vivazome Therapeutics Pty Ltd, 2021
Traumatic Brain Injury - Pipeline by Wesana Health, 2021
Traumatic Brain Injury - Pipeline by Xcelthera INC, 2021
Traumatic Brain Injury - Pipeline by Xonovo Inc, 2021
Traumatic Brain Injury - Pipeline by ZyVersa Therapeutics Inc, 2021
Traumatic Brain Injury - Dormant Projects, 2021
Traumatic Brain Injury - Dormant Projects, 2021 (Contd..1)
Traumatic Brain Injury - Dormant Projects, 2021 (Contd..2)
Traumatic Brain Injury - Dormant Projects, 2021 (Contd..3)
Traumatic Brain Injury - Dormant Projects, 2021 (Contd..4)
Traumatic Brain Injury - Dormant Projects, 2021 (Contd..5)
Traumatic Brain Injury - Discontinued Products, 2021
List of Figures
Number of Products under Development for Traumatic Brain Injury, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
Global CNS Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 03-Oct-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global CNS Therapeutics market:
According to our latest research, the global CNS Therapeutics market looks promising in the next 5 years. As of 2022, the global CNS Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Central nervous system (CNS) disease is a widespread condition in which the brain does not function properly, limiting health and function. The......
Global CNS Therapeutics Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 117
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Central Nervous System Disorders Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application
Published: 18-Apr-2023 Price: US 3500 Onwards Pages: 131
This report describes the global market size of Central Nervous System Disorders Therapeutics from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2028. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for ......
Global CNS Therapeutics Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 16-Mar-2023 Price: US 3260 Onwards Pages: 117
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Global CNS Therapeutics Market Research Report 2023
Published: 06-Feb-2023 Price: US 2900 Onwards Pages: 103
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
CNS Therapeutics Market, Global Outlook and Forecast 2023-2029
Published: 03-Feb-2023 Price: US 3250 Onwards Pages: 100
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
Global Central Nervous System Disorders Therapeutics Market Growth (Status and Outlook) 2023-2029
Published: 02-Feb-2023 Price: US 3660 Onwards Pages: 88
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
LPI (LP Information)' newest research report, the "Central Nervous System Disorders Therapeutics Industry Forecast" looks at past sales and reviews total world Central Nervous System Disorders Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Central Nervous System Disorder......
Global Central Nervous System Disorders Therapeutics Market Research Report 2023
Published: 31-Jan-2023 Price: US 2900 Onwards Pages: 84
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
Highlights
The global Central Nervous System Disorders Therapeutics market was valued at US$ 134580 million in 2022 and is anticipated to reach US$ 169200 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating......
Central Nervous System Disorders Therapeutics Market, Global Outlook and Forecast 2023-2029
Published: 31-Jan-2023 Price: US 3250 Onwards Pages: 69
Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and ma......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
